Surgical site infection (SSI) affects 1 in 20 surgical patients and is an important cause of avoidable postoperative morbidity. Widespread use of antimicrobial drugs to prevent SSI is standard ...

[15] The ENOXACAN 2 trial showed that continuing prophylaxis with enoxaparin until 30 days after surgery significantly reduced the risk of VTE (by 60%, 95% CI 10-82%), from 12% to 4.8%. No ...

† Dose injected directly into vein or running intravenous fluids. ‡ Intermittent intravenous infusion. § Aminoglycosides are not recommended for patients with renal insufficiency as less ...

Antibiotic prophylaxis was associated with reduced risks for surgical site infection (SSIs) and readmissions in children ...